8K7 — UG Healthcare Cashflow Statement
0.000.00%
Last trade - 00:00- SG$64.88m
- SG$84.28m
- SG$115.21m
- 55
- 68
- 69
- 73
Annual cashflow statement for UG Healthcare, fiscal year end - June 30th, SGD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 18.1 | 159 | 48.8 | -28.4 | -9.09 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 0.089 | 1.25 | 4.96 | -13.4 | -4.81 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -9.62 | -82.5 | -3.68 | -3.01 | -8.13 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 11 | 81.2 | 54 | -41.3 | -18.2 |
| Capital Expenditures | -3.29 | -19.7 | -22.3 | -8.03 | -2.55 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.441 | 0.809 | 1.13 | 2.15 | -20.2 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -2.85 | -18.9 | -21.2 | -5.88 | -22.7 |
| Financing Cash Flow Items | — | — | — | 0.041 | -0.01 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -3.74 | -3.14 | -0.973 | 8.74 | 8.36 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 4.4 | 59.1 | 31.8 | -38.4 | -33.8 |